Trump presses to cut prices, weight loss drug companies' stock prices fluctuate
Trump pressured to cut prices, and the stock prices of diet drug companies Eli Lilly and Novo Nordisk fluctuated, the precious metals sector continued its upward trend
Why the Market Is "Wrongly Killing" HIMS After the Trump News
The market panicked after President Trump vowed to slash weight-loss drug prices to $150. In the chaos, $Hims & Hers Health Inc.(HIMS)$ stock plummeted, with investors assuming its business was impacted. Hims is a telehealth platform, not just a compounder. They are a reseller. A massive price drop will lead to a massive increase in sales volume. The single biggest barrier to these drugs is the $1,000+ price tag. If that barrier is removed, millions of new customers will flood the market. Where will they go? They will seek the easiest, most frictionless platform. Hims, with its powerful brand and simple telehealth service, is perfectly positioned to capture this enormous new wave of demand. Even if the profit per prescription shrink
Why the Market Is "Wrongly Killing" HIMS After the Trump News
The market panicked after President Trump vowed to slash weight-loss drug prices to $150. In the chaos, $Hims & Hers Health Inc.(HIMS)$ stock plummeted, with investors assuming its business was impacted. Hims is a telehealth platform, not just a compounder. They are a reseller. A massive price drop will lead to a massive increase in sales volume. The single biggest barrier to these drugs is the $1,000+ price tag. If that barrier is removed, millions of new customers will flood the market. Where will they go? They will seek the easiest, most frictionless platform. Hims, with its powerful brand and simple telehealth service, is perfectly positioned to capture this enormous new wave of demand. Even if the profit per prescription shrink